Dylan Millson

Dylan Millson currently serves as a Business Development Manager at New Amsterdam Genomics since May 2023. Prior experience includes roles as a Consultant and Associate Consultant at Trinity Life Sciences from August 2021 to March 2023, and a Research Associate at Dana-Farber Cancer Institute, where research focused on therapeutic vulnerabilities in myeloid malignancies from June 2020 to August 2021. Dylan also completed research internships at the University of Virginia, examining anti-tumor properties of bispecific antibodies, and at the University of Colorado Anschutz Medical Campus, investigating the role of cholesterol in therapy resistance in ovarian cancer. Educational achievements include a Bachelor of Arts in Chemistry and Biology from Williams College (2016-2020) and attendance at the North Carolina School of Science and Mathematics (2014-2016).